Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Correction: The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell Survival.

PMID: 29282310
Journal: JOURNAL OF IMMUNOLOGY
Year: 2018
Reference: J Immunol. 2018 Feb 1;200(3):1227. doi: 10.4049/jimmunol.1701691. Epub 2017 Dec 27.
Impact factor: 4.539
Publication type: Letter or abstract
Authors: Ainsua-Enrich, Erola, Serrano-Candelas, Eva, Alvarez-Errico, Damiana, Picado, Cesar, Sayos, Joan, Rivera, Juan, Martin, Margarita et al.
DOI: 10.4049/jimmunol.1701691

Correction: The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell Survival.

PMID: 29282310
Journal: JOURNAL OF IMMUNOLOGY
Year: 2018
Reference: J Immunol. 2018 Feb 1;200(3):1227. doi: 10.4049/jimmunol.1701691. Epub 2017 Dec 27.
Impact factor:
Publication type: Letter or abstract
Authors: Ainsua-Enrich, Erola; Alvarez-Errico, Damiana; Martin, Margarita; Picado, Cesar; Rivera, Juan; Sayos, Joan; Serrano-Candelas, Eva et al.
DOI: 10.4049/jimmunol.1701691

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

PMID: 29243205
Journal: Targeted Oncology
Year: 2018
Reference: Target Oncol. 2018 Feb;13(1):79. doi: 10.1007/s11523-017-0544-z.
Impact factor: 3.877
Publication type: Letter or abstract
Authors: Ramos, Francisco Javier, Galan, Maica, Lopez, Rafael, Garcia-Alfonso, Pilar, Ales-Martinez, Jose Enrique, Queralt, Bernardo, Anton, Antonio, Carrato, Alfredo, Gravalos, Cristina, Mendez-Vidal, Maria Jose et al.
DOI: 10.1007/s11523-017-0544-z

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

PMID: 29243205
Journal: Targeted Oncology
Year: 2018
Reference: Target Oncol. 2018 Feb;13(1):79. doi: 10.1007/s11523-017-0544-z.
Impact factor:
Publication type: Letter or abstract
Authors: Ales-Martinez, Jose Enrique; Alsina, Maria; Anton, Antonio; Aranda, Enrique; Carrato, Alfredo; de Mena, Inmaculada Ruiz; Galan, Maica; Garcia-Alfonso, Pilar; Giralt, Jordi; Gravalos, Cristina et al.
DOI: 10.1007/s11523-017-0544-z

Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

PMID: 29473097
Journal: ANNALS OF HEMATOLOGY
Year: 2018
Reference: Ann Hematol. 2018 May;97(5):923. doi: 10.1007/s00277-018-3277-x.
Impact factor: 2.845
Publication type: Letter or abstract
Authors: Bergua, Juan, Rodriguez-Veiga, Rebeca, Esteve, Jordi, Vives, Susana, Serrano, Josefina, Vidriales, Belen, Salamero, Olga, Cordon, Lourdes, Sempere, Amparo, Jimenez-Ubieto, Ana et al.
DOI: 10.1007/s00277-018-3277-x

Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

PMID: 29473097
Journal: ANNALS OF HEMATOLOGY
Year: 2018
Reference: Ann Hematol. 2018 May;97(5):923. doi: 10.1007/s00277-018-3277-x.
Impact factor:
Publication type: Letter or abstract
Authors: Benavente, Celina; Bergua, Juan; Boluda, Blanca; Cordon, Lourdes; Diaz-Beya, Marina; Esteve, Jordi; Garrido, Ana; Jimenez-Ubieto, Ana; Martinez, Pilar; Martinez-Cuadron, David et al.
DOI: 10.1007/s00277-018-3277-x

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

PMID: 29177546
Journal: JOURNAL OF NEUROLOGY
Year: 2018
Reference: J Neurol. 2018 Jan;265(1):32. doi: 10.1007/s00415-017-8679-5.
Impact factor: 3.783
Publication type: Letter or abstract
Authors: Alenda, Raquel, Costa-Frossard, Lucienne, Alvarez-Lafuente, Roberto, Espejo, Carmen, Rodriguez-Martin, Eulalia, Sainz de la Maza, Susana, Villarrubia, Noelia, Rio, Jordi, Dominguez-Mozo, Maria I, Alvarez-Cermeno, Jose C et al.
DOI: 10.1007/s00415-017-8679-5

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

PMID: 29177546
Journal: JOURNAL OF NEUROLOGY
Year: 2018
Reference: J Neurol. 2018 Jan;265(1):32. doi: 10.1007/s00415-017-8679-5.
Impact factor:
Publication type: Letter or abstract
Authors: Alenda, Raquel; Alvarez-Cermeno, Jose C; Alvarez-Lafuente, Roberto; Costa-Frossard, Lucienne; Dominguez-Mozo, Maria I; Espejo, Carmen; Montalban, Xavier; Rio, Jordi; Rodriguez-Martin, Eulalia; Sainz de la Maza, Susana et al.
DOI: 10.1007/s00415-017-8679-5

Correction to: Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes.

PMID: 29327297
Journal: BREAST CANCER RESEARCH AND TREATMENT
Year: 2018
Reference: Breast Cancer Res Treat. 2018 Feb;168(1):13-15. doi: 10.1007/s10549-017-4632-7.
Impact factor: 3.605
Publication type: Letter or abstract
Authors: Krekel, Nicole M A, Schoonmade, Linda J, Meijer, Sybren, Rubio, Isabel T, van den Tol, M Petrousjka, Spronk, Pauline E, Negenborn, Vera L, Volders, Jose H et al.
DOI: 10.1007/s10549-017-4632-7

Correction to: Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes.

PMID: 29327297
Journal: BREAST CANCER RESEARCH AND TREATMENT
Year: 2018
Reference: Breast Cancer Res Treat. 2018 Feb;168(1):13-15. doi: 10.1007/s10549-017-4632-7.
Impact factor:
Publication type: Letter or abstract
Authors: Krekel, Nicole M A; Meijer, Sybren; Negenborn, Vera L; Rubio, Isabel T; Schoonmade, Linda J; Spronk, Pauline E; van den Tol, M Petrousjka; Volders, Jose H et al.
DOI: 10.1007/s10549-017-4632-7

Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

PMID: 29318452
Journal: JOURNAL OF NEUROVIROLOGY
Year: 2018
Reference: J Neurovirol. 2018 Jun;24(3):388-389. doi: 10.1007/s13365-017-0613-1.
Impact factor: 3.228
Publication type: Letter or abstract
Authors: Barber, T J, Imaz, A, Boffito, M, Niubo, J, Pozniak, A, Fortuny, R, Davies, N, Mandalia, S, Podzamczer, D, Gazzard, B et al.
DOI: 10.1007/s13365-017-0613-1

Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

PMID: 29318452
Journal: JOURNAL OF NEUROVIROLOGY
Year: 2018
Reference: J Neurovirol. 2018 Jun;24(3):388-389. doi: 10.1007/s13365-017-0613-1.
Impact factor:
Publication type: Letter or abstract
Authors: Alonso, J; Barber, T J; Boffito, M; Davies, N; Fortuny, R; Gazzard, B; Imaz, A; Mandalia, S; Niubo, J; Podzamczer, D et al.
DOI: 10.1007/s13365-017-0613-1

Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.

PMID: 29931516
Journal: CLINICAL RHEUMATOLOGY
Year: 2018
Reference: Clin Rheumatol. 2018 Aug;37(8):2303-2304. doi: 10.1007/s10067-018-4179-y.
Impact factor: 2.141
Publication type: Letter or abstract
Authors: Callejas Moraga, E, Calvo, E, Carbonell, C, Castillo, M J, Chamorro, A J, Colunga, D, Corbella, X, Egurbide, M V, Espinosa, G, Fonollosa, V et al.
DOI: 10.1007/s10067-018-4179-y

Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.

PMID: 29931516
Journal: CLINICAL RHEUMATOLOGY
Year: 2018
Reference: Clin Rheumatol. 2018 Aug;37(8):2303-2304. doi: 10.1007/s10067-018-4179-y.
Impact factor:
Publication type: Letter or abstract
Authors: Callejas Moraga, E; Calvo, E; Carbonell, C; Castillo, Alfredo Guillen-Del; Castillo, M J; Castillo-Palma, Maria Jesus; Chamorro, A J; Colunga, D; Colunga-Arguelles, Dolores; Corbella, X et al.
DOI: 10.1007/s10067-018-4179-y

Correction to: Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

PMID: 30030676
Journal: JOURNAL OF INHERITED METABOLIC DISEASE
Year: 2018
Reference: J Inherit Metab Dis. 2018 Nov;41(6):1295. doi: 10.1007/s10545-018-0236-6.
Impact factor: 4.092
Publication type: Letter or abstract
Authors: Nunez-Manchon, Judit, Ballester-Lopez, Alfonsina, Koehorst, Emma, Linares-Pardo, Ian, Coenen, Danielle, Ara, Ignacio, Rodriguez-Lopez, Carlos, Ramos-Fransi, Alba, Martinez-Pineiro, Alicia, Lucente, Giuseppe et al.
DOI: 10.1007/s10545-018-0236-6

Correction to: Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

PMID: 30030676
Journal: JOURNAL OF INHERITED METABOLIC DISEASE
Year: 2018
Reference: J Inherit Metab Dis. 2018 Nov;41(6):1295. doi: 10.1007/s10545-018-0236-6.
Impact factor:
Publication type: Letter or abstract
Authors: Almendrote, Miriam; Ara, Ignacio; Arenas, Joaquin; Ballester-Lopez, Alfonsina; Coenen, Danielle; Coll-Canti, Jaume; de Castro, Mauricio; Koehorst, Emma; Linares-Pardo, Ian; Lucente, Giuseppe et al.
DOI: 10.1007/s10545-018-0236-6

Correction to: Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of Primary Care Physicians (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC).

PMID: 29294225
Journal: Clinical & Translational Oncology
Year: 2018
Reference: Clin Transl Oncol. 2018 Jun;20(6):803-804. doi: 10.1007/s12094-017-1822-z.
Impact factor: 2.392
Publication type: Letter or abstract
Authors: Fernandez, T, Santolaya, F, Ruiz, A, Munoz, M, Montero, A, Barnadas, A, Algara, M, Cordoba, O, Casas, A, Gonzalez, M et al.
DOI: 10.1007/s12094-017-1822-z

Correction to: Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of Primary Care Physicians (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC).

PMID: 29294225
Journal: Clinical & Translational Oncology
Year: 2018
Reference: Clin Transl Oncol. 2018 Jun;20(6):803-804. doi: 10.1007/s12094-017-1822-z.
Impact factor:
Publication type: Letter or abstract
Authors: Algara, M; Barnadas, A; Casas, A; Cordoba, O; Fernandez, T; Gonzalez, M; Marzo, M; Montero, A; Munoz, M; Ruiz, A et al.
DOI: 10.1007/s12094-017-1822-z

Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017).

PMID: 29305743
Journal: Clinical & Translational Oncology
Year: 2018
Reference: Clin Transl Oncol. 2018 Jan;20(1):110-111. doi: 10.1007/s12094-017-1823-y.
Impact factor: 2.392
Publication type: Letter or abstract
Authors: Cassinello, J, Arranz, J A, Piulats, J M, Sanchez, A, Perez-Valderrama, B, Mellado, B, Climent, M A, Olmos, D, Carles, J, Lazaro, M et al.
DOI: 10.1007/s12094-017-1823-y

Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017).

PMID: 29305743
Journal: Clinical & Translational Oncology
Year: 2018
Reference: Clin Transl Oncol. 2018 Jan;20(1):110-111. doi: 10.1007/s12094-017-1823-y.
Impact factor:
Publication type: Letter or abstract
Authors: Arranz, J A; Carles, J; Cassinello, J; Climent, M A; Lazaro, M; Mellado, B; Olmos, D; Perez-Valderrama, B; Piulats, J M; Sanchez, A et al.
DOI: 10.1007/s12094-017-1823-y

Correction to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.

PMID: 29138898
Journal: INTENSIVE CARE MEDICINE
Year: 2018
Reference: Intensive Care Med. 2018 Jan;44(1):144-152. doi: 10.1007/s00134-017-4979-6.
Impact factor: 15.008
Publication type: Letter or abstract
Authors: Lehmke, J, Sakr, Yasser, Ferrer, Ricard, Reinhart, Konrad, Beale, Richard, Rhodes, Andrew, Moreno, Rui, Timsit, Jean Francois, Brochard, Laurent, Thompson, B Taylor et al.
DOI: 10.1007/s00134-017-4979-6

Correction to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.

PMID: 29138898
Journal: INTENSIVE CARE MEDICINE
Year: 2018
Reference: Intensive Care Med. 2018 Jan;44(1):144-152. doi: 10.1007/s00134-017-4979-6.
Impact factor:
Publication type: Letter or abstract
Authors: Adamik, B; Afonso, S; Aguilar, G; Aisa, T; Albarrak, M; Albis, A; Alexander, P; Allgaeuer, S; Almekhlafi, G; Alsheikhly, A S et al.
DOI: 10.1007/s00134-017-4979-6

Correction to: The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against alpha-Synuclein-Induced Toxicity.

PMID: 29611099
Journal: MOLECULAR NEUROBIOLOGY
Year: 2018
Reference: Mol Neurobiol. 2018 Sep;55(9):7553-7554. doi: 10.1007/s12035-018-1010-3.
Impact factor: 5.076
Publication type: Letter or abstract
Authors: Kim, Hanna, Calatayud, Carles, Guha, Sanjib, Fernandez-Carasa, Irene, Berkowitz, Laura, Carballo-Carbajal, Iria, Ezquerra, Mario, Fernandez-Santiago, Ruben, Kapahi, Pankaj, Raya, Angel et al.
DOI: 10.1007/s12035-018-1010-3

Correction to: The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against alpha-Synuclein-Induced Toxicity.

PMID: 29611099
Journal: MOLECULAR NEUROBIOLOGY
Year: 2018
Reference: Mol Neurobiol. 2018 Sep;55(9):7553-7554. doi: 10.1007/s12035-018-1010-3.
Impact factor:
Publication type: Letter or abstract
Authors: Berkowitz, Laura; Calatayud, Carles; Caldwell, Guy A; Caldwell, Kim A; Carballo-Carbajal, Iria; Consiglio, Antonella; Dalfo, Esther; Ezquerra, Mario; Fernandez-Carasa, Irene; Fernandez-Santiago, Ruben et al.
DOI: 10.1007/s12035-018-1010-3

Publications

Publications searcher

Correction: The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell Survival.

Correction: The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell Survival.

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

Correction to: Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes.

Correction to: Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes.

Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.

Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.

Correction to: Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

Correction to: Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017).

Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017).

Correction to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.

Correction to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.

Correction to: The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against alpha-Synuclein-Induced Toxicity.

Correction to: The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against alpha-Synuclein-Induced Toxicity.

Patronage:

Collaborating:

Accreditations: